The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
NCT Number: NCT04056520
This study is being done to prospectively collect data on subjects having posterior cervical fusion surgery using the Medtronic Infinity system. Researchers plan to collect information from patients having this type of surgery in order to learn more about patient how patients do after the surgery, including the rate of bone healing following surgery.
The goal is for 250 patients to take part in the study or for 500 screws to be used, whichever comes first. Each patient will need a varying amount of screws to be used during their surgery. Because we are measuring the accuracy of each individual screw and the surgeon will likely use multiple screws during each surgery, it is likely that the study will reach its goal of 500 screws before 250 patients are enrolled in the study.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Columbus, Ohio, 43210, United States
This is a prospective single arm study of clinical and radiological outcomes as well as surgical data from posterior cervical fusion for treating degenerative disc disease (DDD). Patients undergoing posterior cervicothoracic fusions between C2 and upper thoracic will be enrolled.
Patients will be enrolled up to 250 patients (at maximum) or 500 screws, whichever is achieved first. This will adequately power the study assuming 95% screw accuracy, which is in line with published data, and assuming precision of +/- 2% with a confidence level of 9%.
The primary objective of this study is to show that the Medtronic Infinity System is safe and effective in posterior cervicothoracic fusion surgeries. Outcomes measures and complication rates will be compared to historical controls. Secondary objectives include screw accuracy rates/revision rates which can also be compared to historical controls. Other secondary objectives aim to clarify the workflow and operative time of using the O-arm and Stealth navigation for these types of cases.
Subjects will be monitored for adverse events throughout the duration of the study, particularly at and around the time of standard of care clinical assessments. The number of CT related adverse events will be evaluated. The monitoring will be performed by the investigator and study clinical research coordinator. The monitoring will occur both when a quarter and a half of the study patients have been enrolled. The study will be stopped should any significant CT related adverse events be identified.
The following data will be collected
Patient demographic and pre-operative clinical information will include:
Patient surgical details to be collected will include:
Post-operative clinical information will include:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The INFINITY™ OCT System is intended to provide immobilization and stabilization of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the craniocervical junction, the cervical spine (C1 to C7), and the thoracic spine from T1-T3:
Time frame: 49 Days
All Procedure related adverse events
Time frame: 49 Days
MMT Score 1-5 where higher score represents better outcome
Time frame: 49 Days
Sensory Function Score 0-2 where higher score represents better outcome
Time frame: 49 Days
Reflex Score 0-4 where a score of 2 represents best outcome
Time frame: 49 Days
Disease non-specific measure of health related physical functioning presented as T-scores with a mean of 50 and standard deviation of 10 with a higher score indicating better outcome
Time frame: 49 Days
Disease non-specific measure of health related ability to participate presented as T-scores with a mean of 50 and standard deviation of 10 with a higher score indicating better outcome
Time frame: 49 Days
Disease non-specific measure of health related anxiety presented as T-scores with a mean of 50 and standard deviation of 10 with a lower score indicating better outcome
Time frame: 49 Days
Disease non-specific measure of health related depression presented as T-scores with a mean of 50 and standard deviation of 10 with a lower score indicating better outcome
Time frame: 49 Days
Disease non-specific measure of health related fatigue presented as T-scores with a mean of 50 and standard deviation of 10 with a lower score indicating better outcome
Time frame: 49 Days
Disease non-specific measure of health related sleep presented as T-scores with a mean of 50 and standard deviation of 10 with a higher score indicating better outcome
Time frame: 49 Days
Disease non-specific measure of health related pain intensity presented as T-scores with a mean of 50 and standard deviation of 10 with a lower score indicating better outcome
Time frame: 49 Days
Cervical Sagittal Alignment measured on pre- and post-operative radiographs
Time frame: 49 Days
Hoffmann's Response Test measured as Positive or Negative with negative representing the better outcome
Time frame: 49 Days
Spurling's Compression Test measured a Positive or Negative with negative representing the better outcome
Time frame: 49 Days
All Adverse Events and Serious Adverse Events for study duration
Time frame: 49 Days
Screw placement accuracy assessed using modified Gertzbein & Robbins Scale with a score range of 0-4 with lower score indicating better outcome
Time frame: 49 Days
Time to place screw
Time frame: 49 Days
Rate of Screw Repositioning Intraoperatively
Time frame: 49 Days
Level of Surgical Positioning
Time frame: 30 Days
Rate of Perioperative AEs within 30 days post-op
Time frame: 30 Days
Time from surgical procedure start to end
Time frame: 30 Days
Blood Loss during surgery measured in cc
Time frame: 30 Days
Length of Hospital Stay measured in days
Ohio State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06199999
Bone Diseases, Confusion
Iowa City, Iowa, United States
View Trial DetailsNCT04984629
Back Pain, Bone Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT04416321
Bone Diseases, Degenerative Disc Disease
Lancaster, Pennsylvania, United States
View Trial DetailsNCT00948532
Back Pain, Bone Diseases
La Jolla, California, United States
View Trial Details